| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | MYOKARDIA INC | 100,000 | 1,295,000 | 0.01% | ||
| 102 | UNIQURE NV | 230,000 | 1,288,000 | 0.01% | ||
| 103 | SERES THERAPEUTICS INC | 125,000 | 1,238,000 | 0.01% | ||
| 104 | COLUCID PHARMACEUTICALS ORD | 30,310 | 1,103,000 | 0.01% | ||
| 105 | RITTER PHARMACEUTICALS INC | 400,000 | 1,084,000 | 0.01% | ||
| 106 | ProQR Therapeutics NV | 212,698 | 1,042,000 | 0.01% | ||
| 107 | MEDIWOUND ORD | 226,000 | 1,035,000 | 0.01% | ||
| 108 | PALATIN TECHNOLOGIES INC COM | 2,050,000 | 1,035,000 | 0.01% | ||
| 109 | FIVE PRIME THERAPEUTICS INC | 19,247 | 964,000 | 0.01% | ||
| 110 | MADRIGAL PHARMACEUTICALS INC | 57,762 | 861,000 | 0.01% | ||
| 111 | CELLECTIS S A | 50,000 | 848,000 | 0.01% | ||
| 112 | TENAX THERAPEUTICS INC | 420,000 | 819,000 | 0.01% | ||
| 113 | IMMUNE DESIGN CORP | 148,937 | 819,000 | 0.01% | ||
| 114 | INFINITY PHARMACEUTICALS INC | 580,400 | 784,000 | 0.01% | ||
| 115 | Aldeyra Therapeutics Inc | 142,000 | 760,000 | 0.01% | ||
| 116 | Proteon Therapeutics Inc | 389,394 | 740,000 | 0.01% | ||
| 117 | ACCELERON PHARMA INC | 28,765 | 734,000 | 0.01% | ||
| 118 | AFFIMED N V COM | 400,000 | 720,000 | 0.01% | ||
| 119 | CYMABAY THERAPEUTICS INC | 309,268 | 535,000 | 0.01% | ||
| 120 | CHIMERIX INC | 115,216 | 530,000 | 0.01% | ||
| 121 | ARBUTUS BIOPHARMA CORP | 180,582 | 442,000 | 0.00% | ||
| 122 | ALNYLAM PHARMACEUTICALS INC | 11,340 | 425,000 | 0.00% | ||
| 123 | ADAPTIMMUNE THERAPEUTICS PLC | 100,000 | 405,000 | 0.00% | ||
| 124 | Foundation Medicine | 20,892 | 370,000 | 0.00% | ||
| 125 | BIODELIVERY SCIENCES INTL IN | 210,021 | 368,000 | 0.00% | ||
| 126 | CHEMOCENTRYX INC | 49,064 | 363,000 | 0.00% | ||
| 127 | APTOSE BIOSCIENCES INC | 258,311 | 359,000 | 0.00% | ||
| 128 | WINDTREE THERAPEUTICS INC | 254,973 | 319,000 | 0.00% | ||
| 129 | Sierra Oncology, Inc. | 200,000 | 298,000 | 0.00% | ||
| 130 | DYNAVAX TECHNOLOGIES CORP | 75,000 | 296,000 | 0.00% | ||
| 131 | LA JOLLA PHARMACEUTICAL CO | 13,746 | 241,000 | 0.00% | ||
| 132 | CYCLACEL PHARMACEUTICALS INC | 13,253 | 82,000 | 0.00% | ||
| 133 | BIOTIME INC | 20,084 | 14,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-17-008836, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
